Foster & Motley Inc. Reduces Position in HCA Healthcare, Inc. (NYSE:HCA)

Foster & Motley Inc. trimmed its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 0.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 34,213 shares of the company’s stock after selling 143 shares during the quarter. HCA Healthcare comprises 0.9% of Foster & Motley Inc.’s holdings, making the stock its 20th largest position. Foster & Motley Inc.’s holdings in HCA Healthcare were worth $13,905,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Terra Nova Asset Management LLC lifted its holdings in HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after acquiring an additional 26 shares during the period. Massmutual Trust Co. FSB ADV increased its holdings in HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares in the last quarter. Waldron Private Wealth LLC grew its position in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after acquiring an additional 29 shares during the period. Brookstone Capital Management boosted its position in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after purchasing an additional 30 shares in the last quarter. Finally, UMB Bank n.a. raised its stake in shares of HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after buying an additional 30 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.70% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Leerink Partners upped their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. UBS Group lifted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. KeyCorp lowered their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Morgan Stanley started coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Finally, StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $379.11.

Get Our Latest Research Report on HCA

HCA Healthcare Trading Up 1.0 %

HCA opened at $366.66 on Wednesday. The business has a fifty day simple moving average of $392.01 and a 200-day simple moving average of $355.77. HCA Healthcare, Inc. has a 52 week low of $226.44 and a 52 week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market cap of $92.87 billion, a P/E ratio of 16.46, a P/E/G ratio of 1.37 and a beta of 1.68.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.72%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.